Background: Although there are few reports of radiofrequency lesions performed through deep brain stimulation (DBS) electrodes in patients with movement disorders, experience with this method is scarce. Methods: We present 2 patients who had been previously treated with DBS of subthalamic nuclei (STN) and the ventral intermediate (VIM) nucleus of the thalamus for Parkinson's disease and essential tremor, respectively, and underwent a radiofrequency lesion through their DBS electrodes after developing a hardware infection. The authors conduct a review of the literature regarding this method. Results: Both patients had a good clinical outcome after 20 and 8 months, respectively, as assessed by a reduction in Fahn-Tolosa-Marin Scale and Unified Parkinson's Disease Rating Scale scores. The second patient underwent a second DBS system implantation surgery after his radiofrequency treatment to optimize his management, achieving optimal clinical control with lower current and drug requirements than before the radiofrequency intervention. No adverse effects were observed. Conclusions: Radiofrequency lesions through DBS electrodes allow the creation of small and localized lesions. Its effectiveness and low-risk profile, in addition to its low cost, make this procedure suitable and a possible alternative in the therapeutic repertoire for the surgical treatment of movement disorders.

Kleiner-Fisman G, Lozano A, Moro E, Poon Y-Y, Lang AE: Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia. Mov Disord Off J Mov Disord Soc 2010;25:1496-1498.
Schuurman PR, Bosch DA, Merkus MP, Speelman JD: Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression. Mov Disord Off J Mov Disord Soc 2008;23:1146-1153.
Bahgat D, Magill ST, Berk C, McCartney S, Burchiel KJ: Thalamotomy as a treatment option for tremor after ineffective deep brain stimulation. Stereotact Funct Neurosurg 2013;91:18-23.
Alvarez L, Macias R, Pavón N, López G, Rodríguez-Oroz MC, Rodríguez R, et al: Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: results in 89 patients followed for up to 36 months. J Neurol Neurosurg Psychiatry 2009;80:979-985.
Jourdain VA, Schechtmann G, Di Paolo T: Subthalamotomy in the treatment of Parkinson's disease: clinical aspects and mechanisms of action. J Neurosurg 2014;120:140-151.
Cosman ER, Dolensky JR, Hoffman RA: Factors that affect radiofrequency heat lesion size. Pain Med 2014;15:2020-2036.
Hirabayashi H, Hariz MI, Wårdell K, Blomstedt P: Impact of parameters of radiofrequency coagulation on volume of stereotactic lesion in pallidotomy and thalamotomy. Stereotact Funct Neurosurg 2012;90:307-315.
Strickland BA, Jimenez-Shahed J, Jankovic J, Viswanathan A: Radiofrequency lesioning through deep brain stimulation electrodes: a pilot study of lesion geometry and temperature characteristics. J Clin Neurosci 2013;20:1709-1712.
Oh MY, Hodaie M, Kim SH, Alkhani A, Lang AE, Lozano AM: Deep brain stimulator electrodes used for lesioning: proof of principle. Neurosurgery 2001;49:363-367, discussion 367-369.
Raoul S, Faighel M, Rivier I, Vérin M, Lajat Y, Damier P: Staged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias. Mov Disord 2003;18:933-938.
Marras C, Zorzi G, Lenardi C, Rizzi M, Messina G, Alimehmeti R, et al: Deep brain stimulation electrode used for radiofrequency lesion of the globus pallidus internus in dystonia. Stereotact Funct Neurosurg 2009;87:348-352.
Deligny C, Drapier S, Verin M, Lajat Y, Raoul S, Damier P: Bilateral subthalamotomy through DBS electrodes: a rescue option for device-related infection. Neurology 2009;73:1243-1244.
Fasano A, Lozano AM: Deep brain stimulation for movement disorders: 2015 and beyond. Curr Opin Neurol 2015;28:423-436.
Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A: Deep brain stimulation in Parkinson's disease. Ther Adv Neurol Disord 2009;2:20-28.
Raoul S, Leduc D, Vegas T, Sauleau P, Lozano AM, Vérin M, et al: Deep brain stimulation electrodes used for staged lesion within the basal ganglia: experimental studies for parameter validation: laboratory investigation. J Neurosurg 2007;107:1027-1035.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.